Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Carboplatin 62 Paclitaxel 61 Specimen Handling 37 Cisplatin 37 Taxes 35 Magnetic Resonance Spectroscopy 31 Bevacizumab 30 Immunoglobulin G 23 Disulfides 23 Biopsy 22 Cyclophosphamide 19 aldesleukin 17 Topotecan 16 Brachytherapy 16 Radiotherapy 15 Gemcitabine 15 veliparib 14 Oxaliplatin 13 Doxorubicin 13 temsirolimus 12 fludarabine 12 Platinum 12 Docetaxel 12 1,2-diaminocyclohexaneplatinum II citrate 12 olaparib 11 liposomal doxorubicin 10 cediranib 10 Sirolimus 10 Radiation 9 Nivolumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × adacel × Gynecologic × Clear all

NCT05237947 2026-05-28

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡